BEONE MEDICINES LTD. Gross Profit
BEONE MEDICINES LTD. (ONC) reported Gross Profit of $1.53 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-05
- BEONE MEDICINES LTD. gross profit for the quarter ending 2026-06-30 was $1.53B, a 33.01% increase year-over-year.
- BEONE MEDICINES LTD. gross profit for the quarter ending 2026-03-31 was $1.35B, a 41.37% increase year-over-year.
- BEONE MEDICINES LTD. gross profit for the quarter ending 2025-12-31 was $1.36B, a 40.16% increase year-over-year.
- BEONE MEDICINES LTD. gross profit for the quarter ending 2025-09-30 was $1.22B, a 46.28% increase year-over-year.
- BEONE MEDICINES LTD. gross profit for fiscal 2025 was $4.67B, a 45.34% increase from fiscal 2024.
- BEONE MEDICINES LTD. gross profit for fiscal 2024 was $3.22B, a 54.71% increase from fiscal 2023.
- BEONE MEDICINES LTD. gross profit for fiscal 2023 was $2.08B, a 84.06% increase from fiscal 2022.
- BEONE MEDICINES LTD. gross profit for fiscal 2022 was $1.13B, a 11.67% increase from fiscal 2021.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.53B 10-Q · filed 2026-08-05 | $2.88B 10-Q · filed 2026-08-05 | $4.23B derived: sum of 3 quarters · filed 2026-08-05 | $5.45B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.35B 10-Q · filed 2026-05-06 | $2.70B derived: sum of 2 quarters · filed 2026-05-06 | $3.92B derived: sum of 3 quarters · filed 2026-05-06 | $5.07B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.36B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.57B derived: sum of 2 quarters · filed 2026-02-26 | $3.72B derived: sum of 3 quarters · filed 2026-08-05 | $4.67B 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.22B 10-Q · filed 2025-11-06 | $2.37B derived: sum of 2 quarters · filed 2026-08-05 | $3.32B 10-Q · filed 2025-11-06 | $4.29B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.15B 10-Q · filed 2026-08-05 | $2.10B 10-Q · filed 2026-08-05 | $3.07B derived: sum of 3 quarters · filed 2026-08-05 | $3.90B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $952.28M 10-Q · filed 2026-05-06 | $1.92B derived: sum of 2 quarters · filed 2026-05-06 | $2.75B derived: sum of 3 quarters · filed 2026-05-06 | $3.54B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $967.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.80B derived: sum of 2 quarters · filed 2026-02-26 | $2.59B derived: sum of 3 quarters · filed 2026-02-26 | $3.22B 10-K · filed 2026-02-26 |
| 2024-09-30 | $831.14M 10-Q · filed 2025-11-06 | $1.62B derived: sum of 2 quarters · filed 2025-11-06 | $2.25B 10-Q · filed 2025-11-06 | $2.78B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $791.03M 10-Q · filed 2025-08-06 | $1.42B 10-Q · filed 2025-08-06 | $1.95B derived: sum of 3 quarters · filed 2026-02-26 | $2.63B derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $626.72M 10-Q · filed 2025-05-07 | $1.16B derived: sum of 2 quarters · filed 2026-02-26 | $1.84B derived: sum of 3 quarters · filed 2026-02-26 | $2.34B derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $528.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.21B derived: sum of 2 quarters · filed 2026-02-26 | $1.71B derived: sum of 3 quarters · filed 2026-02-26 | $2.08B 10-K · filed 2026-02-26 |
| 2023-09-30 | $685.00M 10-Q · filed 2024-11-12 | $1.18B derived: sum of 2 quarters · filed 2024-11-12 | $1.55B 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $499.27M 10-Q · filed 2024-08-07 | $865.28M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $366.01M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $1.13B 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $1.01B 10-K · filed 2024-02-26 |